DEA Extends Remote Prescribing of Controlled Substances Until 2024
The DEA has extended remote prescribing of controlled substances until the end of 2024, granting a second extension to consider new regulations. This move eliminates the proposed rule requiring in-person visits for controlled medication…
Continue Reading